Literature DB >> 2013771

Venous infarction following the interhemispheric approach in patients with acute subarachnoid hemorrhage.

K Tsutsumi1, Y Shiokawa, T Sakai, N Aoki, M Kubota, I Saito.   

Abstract

Postoperative venous infarction following aneurysm surgery was studied in 48 patients with anterior communicating artery aneurysms operated on through the interhemispheric approach at the acute stage of subarachnoid hemorrhage (SAH). Of 23 patients whose bridging veins were sacrificed during surgery, 11 (47.8%) showed venous infarction in the frontal lobes. In contrast, only one (5.9%) of 17 patients whose bridging veins were preserved developed cerebral edema. None of eight patients who were operated on after Day 11 (the day of SAH was defined as Day 0) showed this complication, although bridging veins were sacrificed in six of them. Venous infarction following acute aneurysm surgery tended to occur more frequently in patients of higher SAH grade and/or more advanced age, but these correlations were not significant. However, the correlation between the sacrifice of veins and venous infarction was significant (p less than 0.025). Because this potential complication may compromise the benefit of acute aneurysm surgery and cause damage, it is important to preserve the venous system and in some instances to select another surgical approach based on the pattern of venous drainage in the frontal lobe.

Entities:  

Mesh:

Year:  1991        PMID: 2013771     DOI: 10.3171/jns.1991.74.5.0715

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  13 in total

1.  Surgery of the anterior part of the frontal lobe and of the central region: normative morphometric data based on magnetic resonance imaging.

Authors:  Ardeshir Ardeshiri; Ardavan Ardeshiri; Emanuel Wenger; Markus Holtmannspötter; Peter A Winkler
Journal:  Neurosurg Rev       Date:  2006-08-16       Impact factor: 3.042

2.  Monitoring of venous blood flow velocity during interhemispheric approach for deep seated lesions.

Authors:  T Morimoto; T Yamada; Y Ishida; H Nakase; T Hoshida; T Sakaki
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

3.  Interhemispheric transcallosal approach: going further based on the vascular anatomy.

Authors:  Sorin Aldea; Caroline Apra; Dorian Chauvet; Caroline Le Guérinel; Pierre Bourdillon
Journal:  Neurosurg Rev       Date:  2021-01-19       Impact factor: 3.042

4.  Anterior interhemispheric approach for clipping of subcallosal distal anterior cerebral artery aneurysms: case series and technical notes.

Authors:  Satoshi Kiyofuji; Shigeo Sora; Christopher S Graffeo; Avital Perry; Michael J Link
Journal:  Neurosurg Rev       Date:  2019-06-11       Impact factor: 3.042

5.  The interhemispheric approach in children: our experience and review of the literature.

Authors:  Jehuda Soleman; Roee Ber; Shlomi Constantini; Jonathan Roth
Journal:  Childs Nerv Syst       Date:  2019-01-07       Impact factor: 1.475

6.  Frequency and topographic distribution of brain lesions in pediatric cerebral venous thrombosis.

Authors:  M Teksam; M Moharir; G Deveber; M Shroff
Journal:  AJNR Am J Neuroradiol       Date:  2008-08-07       Impact factor: 3.825

7.  Anterior Cingulate Cortex Implants for Alcohol Addiction: A Feasibility Study.

Authors:  Sook Ling Leong; Paul Glue; Patrick Manning; Sven Vanneste; Louisa Joyce Lim; Anusha Mohan; Dirk De Ridder
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 6.088

8.  Postoperative cerebral venous infarction.

Authors:  Deepak Agrawal; Vikas Naik
Journal:  J Pediatr Neurosci       Date:  2015 Jan-Mar

9.  Cerebral venous infarction: a potentially avoidable complication of deep brain stimulation surgery.

Authors:  Takashi Morishita; Michael S Okun; Adam Burdick; Charles E Jacobson; Kelly D Foote
Journal:  Neuromodulation       Date:  2013-06-05

10.  Closure of the sigmoid sinus in lateral skull base surgery.

Authors:  E Zanoletti; D Cazzador; C Faccioli; A Martini; A Mazzoni
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-06       Impact factor: 2.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.